Literature DB >> 23396164

MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis.

Ivan Vannini1, Francesca Fanini, Muller Fabbri.   

Abstract

Lung cancer is the leading cause of cancer deaths worldwide and few genetic markers enable to evaluate lung cancer risk. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression during various cell processes such as apoptosis, differentiation and development. In these last years, many works confirm a role for miRNAs in the initiation and progression of lung cancer. miRNA profiling has the potential to classify tumors with high accuracy and predict outcome. Here, we describe the roles of miRNA in lung carcinogenesis and the possibility to use them as biological markers for diagnostic, prognostic and predictive purposes.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396164     DOI: 10.1016/j.clinbiochem.2013.01.024

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  23 in total

1.  Effects of four single nucleotide polymorphisms in microRNA-coding genes on lung cancer risk.

Authors:  Xiaohong Fan; Zhijun Wu
Journal:  Tumour Biol       Date:  2014-07-31

2.  MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9.

Authors:  Sida Liu; Han Dong; Hui Dai; Danwei Liu; Zhihao Wang
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

3.  Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.

Authors:  Chaohui Wu; Minjie Li; Chao Hu; Hongbing Duan
Journal:  Mol Biol Rep       Date:  2014-01-05       Impact factor: 2.316

4.  MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.

Authors:  Duo Li; Dong-Qiong Li; Dan Liu; Xiao-Jun Tang
Journal:  Cell Oncol (Dordr)       Date:  2016-01-07       Impact factor: 6.730

5.  miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.

Authors:  D Petriella; S De Summa; R Lacalamita; D Galetta; A Catino; A F Logroscino; O Palumbo; M Carella; F A Zito; G Simone; S Tommasi
Journal:  Tumour Biol       Date:  2015-11-13

6.  A DRD1 polymorphism predisposes to lung cancer among those exposed to secondhand smoke during childhood.

Authors:  Ana I Robles; Ping Yang; Jin Jen; Andrew C McClary; Kara Calhoun; Elise D Bowman; Kirsi Vähäkangas; K Leigh Greathouse; Yi Wang; Susan Olivo-Marston; Angela S Wenzlaff; Bo Deng; Ann G Schwartz; Bríd M Ryan
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-03

7.  Diagnostic value of microRNA-21 in the diagnosis of lung cancer: evidence from a meta-analysis involving 11 studies.

Authors:  Renjie Wu; Yingjiu Jiang; Qingcheng Wu; Qiang Li; Dan Cheng; Ling Xu; Cheng Zhang; Ming Zhang; Ling Ye
Journal:  Tumour Biol       Date:  2014-06-01

8.  Effects of miR-132-3p on progress and epithelial mesenchymal transition of non-small cell lung cancer via regulating KLF7.

Authors:  Ning Wang; Ye Xu; Qingkui Guo; Chen Zhu; Wen Zhao; Wenliang Qian; Min Zheng
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

9.  The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.

Authors:  K Mavridis; F Gueugnon; A Petit-Courty; Y Courty; A Barascu; S Guyetant; A Scorilas
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

10.  Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma.

Authors:  Renhua Song; Qian Liu; Gyorgy Hutvagner; Hung Nguyen; Kotagiri Ramamohanarao; Limsoon Wong; Jinyan Li
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.